Scancell Holdings Share Price (SCLP)

Morning Konar,
The trial has already officially started in Sept and is listed on CT website but says FPI is the real measure of the trial being underway imo and as Bermuda says there may be other preparations to be completed.
At least there will be plenty of availability of trial volunteers unlike the SCIB 1 trial which has as we know has been officially started fir some time.

Also interesting to note that estimated start date is showing as September. So 1st patient dosed can't be far off.

Kashdog, not pure gambling (unless the trader were reckless enough to commit their entire holding to trading).
I agree with you (and have said as much on this forum) that Buy and Hold is a difficult way forward to argue with, but the commitment of a block of shares to "trading the range" over the last six months or so has been a worthwhile process with which I am sure that anyone who subscribes to the "every little helps" approach will concur.
One day there will be a breakout and that trade won't work and that is to be expected, but if kept within sensible proportions no damage done.
I guess my overriding point was that the stability (but clearly defined ranges) that SCLP has shown over the last six or seven months has been not only a bit of a gift but also a very unusual opportunity for any LTH (who like me might not have been clever enough to sell at the 27.5p level) should they have chosen to follow that path.
I'm very much hoping for that illusive breakout on the upside..... I will welcome its arrival at any time, but until it does the continuance of the range will I'm sure be enjoyed by some; particulaly those who know where the top and the base levels are (of which I do not claim ti be one.
Anyway, while we wait IMO I'm sure some (to varying degrees) will have benefitted from SCLP's new found status and hence relaive stability.

https://scienmag.com/adjuvant-immunotherapy-prolongs-recurrence-free-survival-in-resected-stage-ii-b-c-melanoma/

AB, not sure I agree with your first statement, following the rise in Feb it has fluctuated in a tight range, such that trading within the spread would be pure gambling without much room for profit.
I guess some may have made a little but looking at the size of the majority of trades from feb to date, I doubt many would have collected a retirement fund.
Buy and hold is the right strategy in my opinion ( for what it’s worth) but even that view is based on what I feel is generally held optimistic view that one or more of the platforms will come through.
I see little or no negative comment on this board but there are a couple of reasons why an “insurance” strategy should be considered e.g. failure of one or more trials, for whatever reason and failure of the company to effectively monetise.
Let me state that I am optimistic but have been burned in the past when I thought “this cannot fail”.